Search:

FDA Approval Headlines from PR Newswire


< Go Back

Press Statement on Behalf of the Singh Family (The Former Shareholders and Founders of Ranbaxy)
BioElectronics and Pulsed Shortwave Therapy Make Progress
Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease
Varian Medical Systems Receives FDA 510(k) Clearance of its Nexus DRF Digital X-Ray Imaging System
Bausch + Lomb Receives FDA Approval for the TRULIGN™ Toric Posterior Chamber Intraocular Lens
BioElectronics Presents FDA Reclassification Panel
Hologic Receives FDA Approval for a New Low-dose 3D Mammography (Breast Tomosynthesis) Solution for Breast Cancer Screening
Muscle Warfare a wholly owned subsidiary of Embark Holdings (EMBK) passes inspection by the FDA
New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy
FDA Sets 17 July 2013 For MOXDUO® Advisory Committee Meeting
Thoratec Announces FDA Approval Of HeartMate II® Pocket Controller™
Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S.
Mylan Launches Generic Tricor® Tablets
Syneron Introduces Enhancements to its Innovative Body Shaping Products
TaiGen Biotechnology Announces Submission of New Drug Application for Nemonoxacin in Taiwan and Mainland China
SIMPONI® (golimumab) Receives FDA Approval for Ulcerative Colitis
Mylan Launches Generic Zomig® Tablets
Bayer Receives U.S. FDA Approval for Xofigo® (radium Ra 223 dichloride) Injection as a New Treatment for Castration-Resistant Prostate Cancer with Bone Metastases
MiE's PET SCINTRON Receives FDA Approval
TWi Pharmaceuticals Announces Tentative ANDA Approval for Guanfacine Hydrochloride Extended-Release Tablets
Arbor Pharmaceuticals Announces FDA Approval of First NDA
Breakthrough "AffloVest" Greatly Advances Respiratory Care
CitiusTech's BI-Clinical Platform for Healthcare BI & Analytics Receives NCQA HEDIS Certification
Neuralstem Principal Investigator, Dr. Eva Feldman, Presents Phase I ALS Trial Data At The Romanian Neurological Society Congress
Actavis' NDA for Progestin-Only Patch Accepted for Filing by FDA
Endo Health Solutions Responds to FDA's Denial of OPANA® ER Citizen Petition and the Potential Approval of Additional Non-Abuse Deterrent Formulations of Generic Oxymorphone
BREO™ ELLIPTA™ gains US approval for the treatment of COPD
Novartis drug Ilaris® approved by FDA to treat active systemic juvenile idiopathic arthritis, a serious form of childhood arthritis
Tactical medical device is first of its kind
Hill-Rom Receives FDA 510(k) Clearance to Market MetaNeb 4.0 Airway Clearance System
FDA Grants Premarket Approval (PMA) For The SEDASYS® System For Healthy Patients Undergoing Sedation During Routine Colonoscopy And EGD Procedures
FDA Clears Masimo rainbow® Acoustic Monitoring™ Sensor for Use on Pediatric Patients
FDA Grants Premarket Approval (PMA) For The SEDASYS® System For Healthy Patients Undergoing Sedation During Routine Colonoscopy And EGD Procedures
Scioderm's SD-101 Receives Breakthrough Therapy Designation from FDA for Treatment of Epidermolysis Bullosa
Vyvanse® (lisdexamfetamine dimesylate) Capsules, (CII) Now Approved in the US for Maintenance Treatment in Children and Adolescents with ADHD
Daratumumab Receives Breakthrough Therapy Designation in Double Refractory Multiple Myeloma from U.S. Food and Drug Administration
Clinical Results for Oramed's Oral Diabetes Treatment Published in Peer Reviewed Journal PLOS ONE
BiO2 Medical's IDE Application for the Angel™ Catheter Receives FDA Approval
Raptor Pharmaceutical's PROCYSBI™ Receives FDA Approval for the Treatment of Nephropathic Cystinosis
CSL Behring Receives FDA Approval of Kcentra™ for Urgent Warfarin Reversal in Patients with Acute Major Bleeding
NxStage Announces FDA Clearance for New High Flow Capabilities with NxStage System One
Putney Launches Generic of Baytril® Taste Tabs®
Scioderm's SD-101 Receives Breakthrough Therapy Designation from FDA for Treatment of Epidermolysis Bullosa
Oramed Pharmaceuticals to Present Results of its Key Clinical Studies of Oral Insulin in Type 1 Diabetes Patients at the GTC Diabetes Summit, Boston, MA; April 29-30, 2013
CVRx® Gains Full FDA Approval for Hypertension Study
Chenango County Now One of 15 Authorized Foreign-Trade Zones in NYS
Life Technologies Supports Global Effort to Help Accelerate Emergency Screening of Avian Influenza (H7N9) Virus
ResMed Noninvasive Ventilation Device Cleared by FDA for COPD Treatment
/K I L L K I L L K I L L - Axiom Worldwide, Inc./
Andrew Technologies Receives FDA 510 (k) Clearance for Autologous Fat Transfer with HydraSolve™ Lipoplasty System - First Liposuction Device with this Clearance.

< Prev Next >
PR Newswire - United Business Media